Pharmacotherapy is a major pillar of chronic disease management of chronic kidney disease and type 2 diabetes. To be able assess the quality of pharmacotherapy, this thesis describes the processes of developing and validating two sets of prescribing quality indicators for both chronic kidney disease and type 2 diabetes. It denotes important steps towards a better assessment of quality of prescribing and optimal pharmacotherapy in patients with chronic kidney disease and type 2 diabetes.